These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9679835)

  • 21. Autoimmune markers in slow type 1 diabetes: confrontation to type 1 diabetes.
    Desailloud R; Fajardy I; Vambergue A; Prevost G; Pigny P; Fontaine P
    Diabetes Metab; 2000 Nov; 26(5):353-60. PubMed ID: 11119014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective assessment of islet cell autoantibodies in pancreas organ donors.
    Diamantopoulos S; Allende G; Ferreira JM; Ciancio G; Burke GW; Pugliese A
    Diabetes Care; 2008 Sep; 31(9):1741-2. PubMed ID: 18556338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreas-kidney transplantation and the evolution of pancreatic autoantibodies.
    Martins L; Malheiro J; Henriques AC; Dias L; Dores J; Oliveira F; Seca R; Almeida R; Sarmento AM; Cabrita A; Teixeira M
    Transplant Proc; 2009 Apr; 41(3):913-5. PubMed ID: 19376387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
    Ferber KM; Keller E; Albert ED; Ziegler AG
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
    Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
    PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
    Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic autoantibodies after pancreas-kidney transplantation - do they matter?
    Martins LS; Henriques AC; Fonseca IM; Rodrigues AS; Oliverira JC; Dores JM; Dias LS; Cabrita AM; Silva JD; Noronha IL
    Clin Transplant; 2014 Apr; 28(4):462-9. PubMed ID: 24655222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. The Swedish Childhood Diabetes Study Group and The Diabetes Incidence in Sweden Study (DISS) Group.
    Kockum I; Lernmark A; Dahlquist G; Falorni A; Hagopian WA; Landin-Olsson M; Li LC; Luthman H; Palmer JP; Sanjeevi CB; Sundkvist G; Ostman IJ
    Horm Metab Res; 1996 Jul; 28(7):344-7. PubMed ID: 8858382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
    Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
    Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrosine-phosphatase and glutamate-decarboxylase antibodies after simultaneous pancreas kidney transplantation: do they have an impact on pancreas graft survival?
    Rodelo-Haad C; Aguera ML; Martinez-Vaquera S; Pendon-Ruiz de Mier MV; Salmeron-Rodriguez MD; Esquivias E; Navarro MD; Rodriguez-Benot A; Aljama P
    Transplant Proc; 2015; 47(1):107-11. PubMed ID: 25645784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.
    Kuglin B; Bertrams J; Linke C; Gries FA; Kolb H
    Klin Wochenschr; 1989 Jan; 67(2):66-73. PubMed ID: 2646470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
    J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Islet cell antibodies].
    Hanafusa T
    Rinsho Byori; 1995 May; 43(5):460-2. PubMed ID: 7783363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological markers of recurrent beta cell destruction in diabetic patients undergoing pancreatic transplantation.
    Thivolet C; Abou-Amara S; Martin X; Lefrancois N; Petruzzo P; McGregor B; Bosshard S; Dubernard JM
    Transplantation; 2000 Jan; 69(1):99-103. PubMed ID: 10653387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
    Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF
    Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Pancreatic Autoantibodies in Pancreas Graft Survival After Pancreas-Kidney Transplantation.
    Pestana N; Malheiro J; Silva F; Silva A; Ribeiro C; Pedroso S; Almeida M; Dias L; Henriques AC; Martins S
    Transplant Proc; 2020 Jun; 52(5):1370-1375. PubMed ID: 32245621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons From Pancreas Transplantation in Type 1 Diabetes: Recurrence of Islet Autoimmunity.
    Burke GW; Vendrame F; Virdi SK; Ciancio G; Chen L; Ruiz P; Messinger S; Reijonen HK; Pugliese A
    Curr Diab Rep; 2015 Dec; 15(12):121. PubMed ID: 26547222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.